688065 凯赛生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.9323.8404.3143.3155.123
总资产报酬率 ROA (%)0.6842.6142.5832.0003.253
投入资产回报率 ROIC (%)0.8903.5413.7012.9234.705

边际利润分析
销售毛利率 (%)36.04034.21531.24728.79435.241
营业利润率 (%)22.00519.23318.64721.48829.015
息税前利润/营业总收入 (%)24.99216.12412.98211.23116.422
净利润/营业总收入 (%)18.79616.07016.04519.32425.097

收益指标分析
经营活动净收益/利润总额(%)82.660114.244108.87384.925101.863
价值变动净收益/利润总额(%)-1.9580.222-1.633-1.742-0.533
营业外收支净额/利润总额(%)-0.200-0.569-0.647-1.196-1.766

偿债能力分析
流动比率 (X)5.1075.8472.5322.2205.951
速动比率 (X)4.5245.1292.1271.7904.846
资产负债率 (%)12.50910.75020.61021.55915.645
带息债务/全部投入资本 (%)4.1300.88611.48710.8726.125
股东权益/带息债务 (%)2,274.76910,950.852745.335791.0821,478.054
股东权益/负债合计 (%)581.759689.393293.516274.962392.567
利息保障倍数 (X)8.246-5.374-2.341-1.123-1.358

营运能力分析
应收账款周转天数 (天)33.10429.75629.84753.94947.911
存货周转天数 (天)228.572217.617234.276363.485314.122